Literature DB >> 29446675

Colorectal Liver Metastasis: Overview of Treatment Paradigm Highlighting the Role of Ablation.

Shree R Venkat1, Prasoon P Mohan1, Ripal T Gandhi2.   

Abstract

OBJECTIVE: The objective of this article is to discuss the current treatment options for colorectal cancer (CRC) liver metastases and the role of ablation.
CONCLUSION: A randomized control trial of ablation combined with chemotherapy showed improved overall survival compared with chemotherapy alone. Local recurrence rates are comparable to those associated with resection when ablative margins of more than 5 mm are achieved and target lesions are smaller than 3 cm. In patients with unresectable disease, ablation for curative intent should be considered.

Entities:  

Keywords:  colorectal cancer; liver metastases; radiofrequency ablation

Mesh:

Year:  2018        PMID: 29446675     DOI: 10.2214/AJR.17.18574

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Hemostasis using re-radiofrequency ablation for hepatic tract bleeding after ultrasound-guided percutaneous radiofrequency ablation of hepatic tumors.

Authors:  Kyoung Doo Song; Min Woo Lee; Hyunchul Rhim; Tae Wook Kang
Journal:  Br J Radiol       Date:  2021-09-19       Impact factor: 3.039

2.  Yttrium-90 Selective Internal Radiation Therapy Plus Cryoablation for Recurrent Adrenocortical Carcinoma With Liver Metastases.

Authors:  Tung-Yen Lin; Kuan-Yu Lin; Hung-Yang Kuo; Kuo-How Huang; Chih-Yuan Wang; Yu-Lin Lin; Shyang-Rong Shih; Po-Chin Liang
Journal:  J Endocr Soc       Date:  2022-06-13

3.  Radiofrequency Ablation versus Stereotactic Body Radiation Therapy in the Treatment of Colorectal Cancer Liver Metastases.

Authors:  Jesang Yu; Dong Hwan Kim; Jungbok Lee; Yong Moon Shin; Jong Hoon Kim; Sang Min Yoon; Jinhong Jung; Jin Cheon Kim; Chang Sik Yu; Seok-Byung Lim; In Ja Park; Tae Won Kim; Yong Sang Hong; Sun Young Kim; Jeong Eun Kim; Jin-Hong Park; So Yeon Kim
Journal:  Cancer Res Treat       Date:  2021-10-13       Impact factor: 5.036

4.  Early Outcomes with Single-antenna High-powered Percutaneous Microwave Ablation for Primary and Secondary Hepatic Malignancies: Safety, Effectiveness, and Predictors of Ablative Failure.

Authors:  Harit Kapoor; Michael J Nisiewicz; Ravi Jayavarapu; Roberto Gedaly; Driss Raissi
Journal:  J Clin Imaging Sci       Date:  2020-03-31

5.  Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.

Authors:  Marina Bortolami; Alessandra Comparato; Clara Benna; Andrea Errico; Isacco Maretto; Salvatore Pucciarelli; Umberto Cillo; Fabio Farinati
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

6.  Single-centre survival analysis over 10 years after MR-guided radiofrequency ablation of liver metastases from different tumour entities.

Authors:  Susann-Cathrin Olthof; Daniel Wessling; Moritz T Winkelmann; Hansjörg Rempp; Konstantin Nikolaou; Rüdiger Hoffmann; Stephan Clasen
Journal:  Insights Imaging       Date:  2022-03-21

7.  Gata6+ resident peritoneal macrophages promote the growth of liver metastasis.

Authors:  Mokarram Hossain; Raymond Shim; Woo-Yong Lee; Arlene H Sharpe; Paul Kubes
Journal:  Nat Commun       Date:  2022-07-29       Impact factor: 17.694

8.  Improved imaging of colorectal liver metastases using single-source, fast kVp-switching, dual-energy CT: preliminary results.

Authors:  Przemysław Ratajczak; Zbigniew Serafin; Agata Sławińska; Maciej Słupski; Waldemar Leszczyński
Journal:  Pol J Radiol       Date:  2018-12-07

Review 9.  Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review.

Authors:  Florentine E F Timmer; Bart Geboers; Sanne Nieuwenhuizen; Evelien A C Schouten; Madelon Dijkstra; Jan J J de Vries; M Petrousjka van den Tol; Martijn R Meijerink; Hester J Scheffer
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.